Sanctions Urged In Celexa, Lexapro Case

Law360, New York (September 7, 2007, 12:00 AM EDT) -- Forest Laboratories Inc. has asked the judge presiding over the multidistrict product liability litigation over blockbuster antidepressants Celexa and Lexapro to dismiss eight suits, arguing the plaintiffs should be punished for allegedly failing to comply with electronic discovery requirements in the wrongful death cases.

On Thursday, lawyers for defendants Forest Labs and Forest Pharmaceuticals Inc. filed a motion in the U.S District Court for the Eastern District of Missouri, seeking to have the claims of Carmen Hill and seven others tossed.

“Despite preservation letters, discussions throughout...
To view the full article, register now.




Case Information

Case Title

In Re: Celexa and Lexapro Products Liability Litigation

Case Number



Missouri Eastern

Nature of Suit

Personal Inj. Prod. Liability


Rodney W. Sippel

Date Filed

February 17, 2006

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.